Background: Crush syndrome (CS) is characterized by ischemia/reperfusion (I/R)-induced rhabdomyolysis and the subsequent onset of systemic inflammation. CS is associated with a high mortality, even when patients are treated with conventional therapy. We hypothesized treatment of lethal CS rat model with dexamethasone (DEX) have therapeutic effects on the laboratory findings and clinical course and outcome.
Introduction Crush syndrome (CS) is a serious medical condition characterized by hypovolemic circulatory shock, hyperkalemic metabolic acidosis, and acute myoglobinuric renal failure and is frequently observed after traumatic events such as earthquakes, landslides, and vehicle accidents 1 .
Currently recommended treatment for CS involves early aggressive volume repletion using normal saline and alkaline diuresis with bicarbonate and mannitol, combined with the correction of hyperkalemia 1 . When such patients demonstrate acute myoglobinuric renal failure that is severe enough to produce refractory hyperkalemia, acidosis, and uremia, transfer to a hospital and hemodialysis are urgently indicated. Although the use of antioxidants and free-radical scavengers has emerged as a promising new approach for the treatment of acute kidney injury 2 and systemic inflammation, controlled studies evaluating their efficacy are currently lacking. At present, no satisfactory treatment has been established for CS because these conventional managements provide only symptomatic management, not treatment of the underlying mechanism.
The most important mechanism causing CS-related mortality is ischemia/reperfusion (I/R)-induced rhabdomyolysis and the subsequent onset of reactive oxygen species (ROS)-mediated systemic inflammation 3, 4 , we therefore directed our therapeutic attention to an old drug, glucocorticoid, which has recently been attracting new research attention due to 1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 the recent recognition of its anti-inflammatory action in a receptor-dependent, but transcription-independent, manner (non-genomic pathway).Recent studies have reported beneficial effects of glucocorticoids in the treatment of experimental I/R injury due to myocardial infarction 5 , cerebral stroke 6 , and kidney damage 7 through the non-genomic pathway, in which glucocorticoid receptor-mediated signaling phosphorylates phosphoinositide 3-kinase (PI3K) and subsequently activates Akt and endothelial nitric oxide synthase (eNOS) 8 . However, there has so far been no experimental evidence of the potential therapeutic benefits of glucocorticoid administration for CS.
We previously reported the development of a practical animal model for crush injury using simple rubber tourniquets compressing the bilateral hind limbs of the rat for 5 hours 9 . This model has a similar clinical appearance to lethal human CS, with a high mortality due to rhabdomyolysis, serious arrhythmia with hyperkalemia, circulatory shock, and remote organ failure, including lung edema and acute renal failure. Using this model, in the present study we investigated the effects of dexamethasone (DEX) on the clinical course and outcome of CS, and showed complete recovery of the rats from lethal crush injury. We also provide evidence of the possible mechanism underlying the anti-I/R injury effects of DEX. Moreover, this study provides a simpler and more useful first-aid treatment for CS, which should be implemented as soon as possible in the field of disaster medicine. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
MATERIALS AND METHODS

Animal model
Male Wistar rats weighing 250-300 g obtained from Kiwa Laboratory Animals (Wakayama, Japan) were housed in a room maintained at a temperature of 23 ± 3 °C and a relative humidity of 55 ± 15% with a 12-h light-dark cycle, with free access to food and water.
All animal experiments were conducted according to the guidelines for animal use approved by the Life Science Research Center of Josai University (approval reference number: H23015). Anesthesia was induced by the intraperitoneal injection of pentobarbital sodium (50 mg/kg body weight). The body temperature was maintained by a heating lamp during the experiment. The CS model was generated as reported previously 9 . In brief, a rubber tourniquet that applied by wrapping five turns around a metal cylinder under a 2 kg load, and the end of the band was glued. After a given period of time, the compression was released by cutting and removing the tourniquet.
Experimental design
The animals were randomly assigned to four groups. Three CS groups were subjected to hind limb compression for 5 hours 9 (SDC Method 1), followed by the infusion of 100 μL of normal saline (CS control group: n=44) or the infusion of 100 μL of different doses of dexamethasone 21-phosphate disodium salt (DEX, SIGMA-ALDRICH) (0.1 or 5.0 mg/kg of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 DEX, CS+DEX-0.1: n=29 and CS+DEX-5.0: n=25, respectively) immediately before reperfusion. A sham group (n=25) serving as a control underwent the same procedures as all the three CS groups except for the compression and decompression with rubber tourniquets.
All rats were placed under anesthesia (intraperitoneal injection of pentobarbital sodium, 50 mg/kg body weight) during the 5 h compression period, then were allowed to recover and were kept without intravenous fluid solution but with oral free access to food and water until they were killed for the sampling of blood and tissues at the designated time periods.
In a separate experiment, four groups of rats (CS control group: n=29; sham and CS+DEX-5.0 groups: n=10; and CS+DEX-0.1 group: n=14) were prepared and observed for 48 h after reperfusion to determine the survival rates.
To compare the therapeutic effects of DEX with the conventional therapies such us early fluid resuscitation and/or correction of acidosis, another set of experiment was also performed using the CS rats treated with fluid resuscitation (30mL/kg/hr, starting immediately after reperfusion for first 3 hours) of saline or bicarbonated Ringer's solution (BICARBON ○ R , Ajinomoto Pharmaceutical Co. Ltd. Tokyo).
Recording and analysis of the mean arterial pressure
At the designated time period after reperfusion, each group was re-anesthetized with an intraperitoneal injection of pentobarbital sodium (50 mg/kg body weight) to record the mean 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 arterial blood pressure (MAP). The femoral artery was cannulated with a polyethylene catheter (INTERMEDIC TM PE-50 tubing; Becton Dickinson and Company, Sparks, MD) connected to a pressure transducer. The blood pressures were amplified, displayed, and recorded via a PowerLab™ data acquisition system (AD Instruments, UK).
Blood and tissue sampling
Blood samples from each group were obtained at one, three, six, and 24 h after reperfusion (n=3). The analyses of the pH, PO 2 , PCO 2 , HCO 3 -, and base excess (BE) of the arterial blood obtained from the femoral artery were performed using a blood gas analyzer (i-STAT300F ® , FUSO Pharmaceutical Industries, Ltd., Osaka, Japan). Venous blood from the postcaval vein was sampled and centrifuged to measure the plasma levels of potassium ion (K + ), blood urea nitrogen (BUN), creatinine, creatine phosphokinase (CPK), and lactate dehydrogenase (LDH) (measurements were performed by SRL Inc., Tokyo, Japan). Tissue samples from the gastrocnemius muscles, kidneys, and lungs were subjected to a histological analysis, measurement of the MPO activity, nitrite or nitrate level, and a Western blot analysis.
Nitrite and nitrate concentrations in the muscle and plasma
The nitrite concentrations in muscle were measured using a dedicated HPLC system (ENO-20; Eicom, Kyoto, Japan) according to the method previously reported 3 . 
Plasma levels of interleukin 6 and 10
The plasma levels of interleukin (IL)-6 and 10 (Rat IL-6 and 10 ELISA kit; Endogen, Inc)
were measured by ELISA according to the manufacturer's instructions.
Western blot analysis
According to the method previously reported 6 , the muscle tissue samples obtained from the rats were homogenized and centrifuged Muscle lysates were applied to SDS-PAGE using antibodies against eNOS, P-eNOS (Santa Cruz Biotechnology), Akt, P-Akt, p85, P-p85, iNOS (Cell Signaling), HO-1 (Thermo), and α-tubulin (Cell Signaling). The bound antibodies were visualized using the ECL chemiluminescence detection system (SuperSignal West Dura Extended Duration Substrate, Pierce) with HRP-conjugated secondary antibodies (Pierce).
The band intensity was quantified using a Bio Imaging System, with the Gene Snap and Gene Tools software programs (Syngene Bio Imaging, Cambridge, USA). Control of the protein loading and transfer was conducted by determining the α-tubulin levels. 
Determination of ROS
Histology and MPO activity
For the histological evaluations, tissue samples were collected 3 hours after reperfusion, then fixed in 10% formalin and embedded in paraffin wax. The sections were then cut and stained with hematoxylin and eosin, and were carefully examined microscopically (SDC Method 2). MPO activities in the muscle tissues were measured according to the technique described by Murata et al 9 .
Statistical analysis
The results are expressed as the means ± the standard error of the mean (SEM). ANOVA was used for each of the variables to assess the differences between each group, and Tukey's honestly significant difference test or the Tukey-Kramer test was used to compare the results between groups. Survival curves were calculated by the Kaplan-Meier method, with the level of significance set at p< 0.05, and survival was compared by a log-rank test. Differences were considered to be significant for values of p< 0.05. 
RESULTS
Survival rates
In the present study, crush injury gradually decreased the survival rate in the CS control group, with the survival rate decreasing to 76%, 45%, and 28% at 3, 6, and 18 hours after reperfusion, respectively, then finally to 24% by 48 hours after reperfusion (SDC Figure 1 ).
On the other hand, the treatment of CS rats with CS+DEX-0.1 group significantly improved the survival rate until 18 hours after reperfusion, although it ultimately ended in failure 48 hours after reperfusion, with a final mortality rate similar to the CS control group. However, to our surprise, CS+DEX-5.0 group saved all CS rats, and maintained a 100% survival rate over the 48-hour experimental period (SDC Figure 1 ). On the other hand, the conventional therapies of fluid resuscitation with saline and bicarbonated Ringer's solution for this CS models (30% and 60% of survival rates by 48 hours after reperfusion, respectively) appear to be inferior to DEX treatment in survival rate (SDC Figure 2 ).
Effects of DEX on plasma biochemical markers, mean arterial pressure and blood gas
As shown in Table 1 , the CS control rats showed significant increases in the markers of rhabdomyolysis, such as CPK, K + , and LDH in the plasma as early as one hour after reperfusion, with each peak value observed at 3, 6, and 24 hours after reperfusion, respectively. In Table 2 , the CS control rats showed a significantly decreased MAP   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 throughout the 24-hour experimental period, which consequently induced metabolic acidosis shown in the arterial blood gas analysis (pH, base excess, HCO 3 and lactate). However, DEX remarkably suppressed not only rhabdomyolysis, but also the subsequent hypovolemic hypotension in a dose-dependent manner ( Table 2 ). In addition, the circulatory improvement associated with DEX also decreased the plasma levels of renal damage markers, such as creatinine and BUN, which began to increase at three hours after reperfusion in the CS control rats (Table 1 ). More beneficial effects of DEX were also shown than the conventional therapies of fluid resuscitation on plasma biochemical markers, MAP and blood gas (SDC Table 1 and 2).
DEX-induced NO production through the non-genomic signaling pathway and the subsequent reduction of ROS production
We examined the non-genomic activation of the PI3K-Akt-eNOS signaling pathway in injured muscle by DEX. DEX exhibited a tendency to increase the phosphorylation of the regulatory p85 subunit of PI3K compared with untreated CS rats in the early phase (0.5-3 h) after reperfusion ( Figure 1A) , and CS+DEX-5.0 group significantly activated and amplified the Akt phosphorylation and subsequent eNOS phosphorylation at 1 and 3 hours after reperfusion ( Figures 1B and C ). However, it has been difficult to evaluate the NO production in injured muscle. Because of the difficulty associated with evaluating the biological NO 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 production directly using in vivo studies, we instead measured the muscle levels of nitrite, a stable NO oxidation product indicative of the level of NO production. Activated eNOS produced NO and resulted in increased levels of nitrite in the muscle compared with that in the CS control rats at one hour after reperfusion (Figure 2A ). Despite the increased eNOS phosphorylation (P-eNOS Western blots are shown in Figure 1C ) by DEX, the total eNOS protein expression was not quantitatively different among the groups (normalized by α-tubulin, SDC Figure 3 ). The reduced NO production represented by the decreased nitrite contents in the injured muscle ( Figure 2A ) led to the induction of ROS production and subsequent rhabdomyolysis, but this was blocked only by CS+DEX-5.0 group as early as 3 hours after reperfusion ( Figure 2B ).
Genomic effects of DEX on the expression levels of anti-and pro-inflammatory cytokines
We observed significant increases in the plasma levels of IL-6 and IL-10 in the CS control rats ( Figures 3A and B) , which started at three hours after reperfusion following a transient increase in ROS production in the injured muscle ( Figure 2B ). The increase lasted throughout 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
Effects of DEX on the myeloperoxidase activities in muscle, lung, and kidney
We determined the MPO activities in injured muscle, lung, and kidney tissue. The MPO activities in these organs were found to remarkably increase, especially at three hours after reperfusion, and they lasted for the entire 24-hour experimental period. However, DEX dose-dependently inhibited the MPO activities in the muscle, lungs, and kidneys (Figures
Effects of DEX on the histological findings of the gastrocnemius muscle, lungs, and kidneys
We next examined the histology of CS-induced damages in the muscle, lung and kidney. In comparison with sham rats, the histological changes appeared to be marked in CS rats, and dose-dependently improved by DEX treatment in these tissues (SDC Figures 4-6 ). 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
DISCUSSION
An important finding of the present study is the significantly reduced nitrite content observed in muscle after ischemia (0 h after reperfusion, Figure 2A ) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 phosphorylation of the PI3K-Akt-eNOS signaling pathway ( Figure 1A -C) 22 . However, the tissue levels of nitrite might be an indirect marker for endogenous NO production, because the reaction of NO with oxygen to form nitrite is kinetically unfavorable compared with the reaction of NO with heme proteins, such as hemoglobin and myoglobin, which favorably yield nitrate instead under physiological conditions. On the other hand, NOS-derived NO has been reported to be predominantly oxidized to nitrite by ceruloplasmin, which is upregulated under ischemic conditions 23 . It is therefore possible that the increase in muscle nitrite observed in the present study might be due to either enhanced NO production by DEX and/or a tendency of NO to be oxidized to nitrite in the early phase of the I/R injury (Figure 2A ).
Either way, these results suggest that the early temporary recovery of the NO stores to increase the NO bioavailability may contribute to the DEX-mediated reduction of I/R injury.
In fact, these DEX-activated NO signaling pathways have been well established to have a protective effect against the early phase of I/R injury in other organs, including the myocardium 5 and cerebrum 6 . In line with these observations, we recently reported that the treatment of CS rats with intravenous nitrite before reperfusion enhanced the muscle levels of nitrite, which was associated with reduced rhabdomyolysis and systemic inflammation, with a remarkable improvement in the survival rates 3 . These results clearly indicate that the tissue NO-releasing capacity in the early phase of reperfusion plays an important role in modulating the process of serious I/R injury. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
In addition to the local non-genomic signaling mediated by DEX (as discussed above), prevented the occurrence of lethal remote organ failure (Figure 4 ).
On the other hand, IL-10 is an anti-inflammatory cytokine known to be induced by glucocorticoids via the genomic pathway (transactivation), and it is capable of inhibiting the production of pro-inflammatory mediators, such as TNF-α and IL-6( Figure 3A) . However, the effect of glucocorticoid on the plasma levels of IL-10 still remains controversial, as it has 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 been reported to have the opposite effect or to be biphasic, depending on the type of stimulus, the dose of glucocorticoid, and the study setting (in vivo or in vitro) 29 . Although further studies will be required to delineate this complicated issue, the present study showed the increased plasma levels of IL-10 following I/R injury, possibly reflecting a response to systemic inflammation and the suppressive effect of DEX on local and systemic inflammation could result in decreased plasma levels of IL-10 ( Figure 3B ).
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SOURCES OF FUNDING
SDC Method 1: Experimental design
On reperfusion following ischemia, the vascular endothelium becomes swollen and the vessel lumens are plugged and packed with erythrocytes, leukocytes, and platelets, resulting in the occurrence of a no-reflow phenomenon 1 . However, if the duration of ischemia is not long enough to cause no-reflow phenomenon, cytosolic toxic mediators including myoglobin derived from lysed skeletal muscle cells are released to the circulation following reflow phenomenon, leading to systemic inflammations with high mortality. However, the shorter 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 ischemia duration (less than 4 hours in this model) is, the less cell damages are, resulting in less systemic inflammations with low mortality. We previously reported that a 5-hour bilateral hindlimb ischemia exhibited the highest mortality rate (75%) at 24 hours after reperfusion compared with other durations of ischemia (0% mortality in less than 4-hour ischemia and only 10% mortality in more than 6-hour ischemia) 2 , thereby providing a critical time window to cause reflow and rhabdomyolysis leading to serious CS.
Based on these reports, a 5-hour compression by the tourniquet was chosen for the crush interval in the current study 2,3 which provides a more practical animal model closely similar
to lethal human CS than other animal models.
SDC Method 2: Histology
All sections from tissues were scored by a blinded observer according to the semiquantitative histological scoring systems of skeletal muscle, lung and kidney described in the previous reports 4,5,6 .
SDC Table 1 and 2 : Effects of the conventional therapies on plasma biochemical markers, mean arterial pressure and blood gas of CS rat CS control rats showed significant increases in the markers of rhabdomyolysis, such as CPK, K + , and LDH in the plasma as early as one hour after reperfusion. CS control rats also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 showed a significantly decreased MAP throughout the 24-hour experimental period, which consequently induced metabolic acidosis shown in the arterial blood gas analysis (pH, base excess, HCO 3 and lactate). However, fluid resuscitation (30mL/kg/hr 7,8 , starting immediately after reperfusion for 3 hours) of saline or bicarbonated Ringer's solution (BICARBON ○ R ), significantly suppressed rhabdomyolysis and subsequent hypovolemic hypotension (SDC Table 2 ). The circulatory improvement also decreased the plasma levels of renal damage markers (creatinine and BUN, SDC Table 1 ). These beneficial effects were more observed in the bicarbonated Ringer's solution than saline (SDC Table 1 and 2). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 Lung MPO activity (unit/g tissue)
